Project Grant HT94252510689
Award Date
9/1/25
Completion Date
8/31/27
Dollars Obligated
$306K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Sweden
Similar Awards
The Defense Health Agency awarded a $199,966 project grant to the Ecole Polytechnique Federale De Lausanne (EPFL) in Switzerland under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the funding will be used to conduct research on the foundations supporting neuroprosthetic management of hypotensive complications in...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded Scripps Research Institute, a nonprofit biomedical research organization, a $529,125 project grant to investigate microglia dysfunction in MEF2C deficiency autism spectrum disorder with the goal of discovering targeted therapies. This 3-year award, effective September 30, 2024, will fund research aimed at improving the health and care of military service members, veterans, and their families...
The U.S. Department of the Army Medical Command awarded a $494,774 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Aarhus Universitet, a Danish educational institution, to develop nonmotor biomarkers to diagnose Parkinson's disease subtypes early on. The award, which runs from December 15, 2024 to December 14, 2026, will support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader...
The Defense Health Agency awarded a $998,176 Project Grant to Turun Yliopisto, a Finnish educational institution, to develop new imaging methodology to assess glial cell-driven pathology in multiple sclerosis. The grant is funded through the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The project has a performance period from September 30, 2024 to...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,155,000 Project Grant to the Regents of the University of Minnesota to evaluate prostate cancer patient natural killer cell function across racial backgrounds and address functional disparities with trispecific killer engagers. The award, which runs from June 1, 2025 to May 31, 2029, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans,...
The U.S. Defense Health Agency awarded King's College London a $1,712,517 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to identify molecular predictors of risk and validate the evolution of ductal carcinoma in situ (DCIS) over a 4-year period ending on September 29, 2027. As the prime awardee, King's College London will leverage its expertise in biomedical research to advance the scientific understanding of breast cancer progression. This award supports...
Drexel University was awarded a $302,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 2021 through March 2024 to develop a novel microtubule-based hypothesis for frontotemporal dementia leading to potential therapies for military personnel and veterans. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform...
The U.S. Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) awarded a $199,908 Project Grant to the Institut National De La Sante Et De La Recherche Medicale (Inserm) to model hemangioblastomas using induced pluripotent stem cells carrying mutations in the von Hippel-Lindau gene. This 2-year project, scheduled for completion by April 30, 2026, aims to transform healthcare for Service Members and the American public through innovative biomedical research. As a...
The Department of Defense's Defense Health Agency awarded a $700,032 Project Grant to Duke University under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective August 1, 2025 through July 31, 2029, will fund research to investigate "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in RCC." This research aims to transform healthcare for military service members, veterans, and the broader public by...
The Department of the Army Medical Command awarded a $1,000,000 project grant to Duke University's Office of Research Administration Division under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 1, 2024 and running through May 31, 2027, will fund a practical multi-domain risk model of Alzheimer's disease and related dementias for veteran and non-veteran older U.S. adults. The research project aims to improve the health and care of military service...